Inventor · disambiguated record
M. Michael Wolfe
Also filed as: WOLFE M M · WOLFE M MICHAEL
9 granted patents·15 pending applications·116 citations·filing 1992–2024
84Inventor score
Files withMHS CARE INNOVATION LLC5METROHEALTH VENTURES LLC3WOLFE M M3WOLFE M MICHAEL3BOSTON MEDICAL CT CORP2
Top patents by PatentIndex Score
24 records- 0184US5229137AMethods and pharmaceutical compositions for treating episodic heartburnBRIGHAM & WOMENS HOSPITAL·Filed 1992·Granted Jul 20, 1993·92 cites·27 claims
- 0273US2025304675A1Compositions and methods for treating ischemic heart diseaseMETROHEALTH VENTURES LLC·Filed 2024·Application pending·0 cites
- 0370US12508299B2Compositions and methods for treating obesity and hyperphagiaMETROHEALTH VENTURES LLC·Filed 2022·Granted Dec 30, 2025·0 cites·20 claims
- 0470US7091183B1Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP)BOSTON MEDICAL CT CORP·Filed 1997·Granted Aug 15, 2006·24 cites·10 claims
- 0566US11066467B2Compositions and methods for treating ischemic heart diseaseMHS CARE INNOVATION LLC·Filed 2019·Granted Jul 20, 2021·0 cites·16 claims
- 0666US2021347883A1Compositions and methods for treating ischemic heart diseaseMHS CARE INNOVATION LLC·Filed 2021·Application pending·0 cites
- 0765US11400135B2Compositions and methods for treating obesity and hyperphagiaMHS CARE INNOVATION LLC·Filed 2020·Granted Aug 2, 2022·0 cites·11 claims
- 0861US2025109196A1Compositions and methods for treating ischemic heart diseaseMETROHEALTH VENTURES LLC·Filed 2024·Application pending·0 cites
- 0959US10548951B2Compositions and methods for treating obesity and hyperphagiaMHS CARE INNOVATION LLC·Filed 2017·Granted Feb 4, 2020·0 cites·19 claims
- 1059US2008125371A1Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP)WOLFE M MICHAEL·Filed 2006·Application pending·0 cites
- 1159US2007167374A1Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP)WOLFE M M·Filed 2006·Application pending·0 cites
- 1259US2007173455A1Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP)WOLFE M M·Filed 2006·Application pending·0 cites
- 1358US2008182795A1Specific antagonists for glucose-depenent insulinotropic polypeptide (GIP)BOSTON MEDICAL CT·Filed 2008·Application pending·0 cites
- 1456US2009291883A1Combination of an immunosuppressive agent and nonsteroidal anti -inflammatory drugs to treat diseaseBOSTON MEDICAL CT CORP·Filed 2007·Application pending·0 cites
- 1555US10538586B2Compositions and methods for treating fatty tissue buildupMHS CARE INNOVATION LLC·Filed 2017·Granted Jan 21, 2020·0 cites·13 claims
- 1655US9771422B2Compositions and methods for treating fatty tissue buildupTHE METROHEALTH SYSTEM·Filed 2014·Granted Sep 26, 2017·0 cites·16 claims
- 1751US2007167363A1Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP)WOLFE M M·Filed 2006·Application pending·0 cites
- 1849US2007269531A1Non-Steroid Anti-Inflammatory Agents with Vitamins, Minerals, and Dietary Supplements for the Prevention and Treatment of Primary, Secondary and Tertiary CancerWYETH PATENT LAW DEPT·Filed 2005·Application pending·0 cites
- 1948US10196441B2Compositions and methods for treating fatty tissue buildupTHE METROHEALTH SYSTEM·Filed 2016·Granted Feb 5, 2019·0 cites·19 claims
- 2048US2002151495A1Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP)Filed 2001·Application pending·0 cites
- 2146US2008214619A1Business method to treat and/or prevent a gastric acid disorder with a proton pump inhibitor (PPI) and a cholinergic agonist to induce rapid onset of PPI action with or without foodWOLFE M MICHAEL·Filed 2007·Application pending·0 cites
- 2245US2018140630A1Combination of an h2-receptor antagonist, antacid, and alginic acid to treat episodic heartburnWOLFE M MICHAEL·Filed 2017·Application pending·0 cites
- 2340US2004029805A1Prevention and treatment of nonalcoholic fatty liver disease (NAFLD) by antagonism of the receptor to glucose-dependent insulinotropic polypeptide (GIP)Filed 2003·Application pending·0 cites
- 2437US2003157071A1Treatment or replacement therapy using transgenic stem cells delivered to the gutFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when M. Michael Wolfe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →